UnitedHealth sees minimal impact from rebate system overhaul

By Tamara Mathias and Manojna Maddipatla (Reuters) - UnitedHealth Group Inc said on Tuesday it expects minimal impact to its margins if the rebate system is overhauled but investors remained concerned about the impact of the Trump administration's proposal to end discounts from drugmakers.

Reuters April 17, 2019 04:05:22 IST
UnitedHealth sees minimal impact from rebate system overhaul

UnitedHealth sees minimal impact from rebate system overhaul

By Tamara Mathias and Manojna Maddipatla

(Reuters) - UnitedHealth Group Inc said on Tuesday it expects minimal impact to its margins if the rebate system is overhauled but investors remained concerned about the impact of the Trump administration's proposal to end discounts from drugmakers.

Shares of the company fell 4 percent and dragged down those of rivals Anthem Inc, Centene Corp, Humana Inc and Cigna Corp.

"It goes back to the political pressure on the managed care area," Thomas Martin, senior portfolio manager at GLOBALT Investments in Atlanta said.

"It remains a wild card even though they are proving that their business model is good and are producing good results."

The healthcare sector has come under pressure after the U.S. government in January proposed a rule that would overhaul the use of drug company rebates in government-run healthcare plans.

Adding to investor concerns, U.S. Senator Bernie Sanders recently unveiled the latest version of his "Medicare-for-All" plan that would eliminate private insurance and shift all Americans to a public healthcare plan.

UnitedHealth Chief Executive Officer David Wichmann said some proposals being discussed represent a "wholesale disruption of American healthcare" that would impact the economy and jobs without improving patient access.

On the potential impact from the proposed change to the rebate rule, the company said discounts they currently receive are mostly passed on to clients.

"Ninety percent of what we manage is generic (drugs) with no rebates," said John Prince, a senior company executive.

"Within our total client base, 98 percent of our discounts are passed on to our clients."

Analysts said that despite the recent slump in shares, fundamentals of the industry are still on track.

"But a negative sentiment around the sector is, in the short-term, more than offsetting what we see as a continued positive fundamental trajectory for UnitedHealth," Stephens Inc analyst Scott Fidel said.

UnitedHealth on Tuesday raised its full-year adjusted earnings forecast to between $14.50 and $14.75 per share from its prior view of $14.40 to $14.70.

Optum, the company's fastest-growing unit which houses its pharmacy benefits business, brought in sales of $26.36 billion in the quarter, a jump of nearly 12 percent from a year earlier due to higher prescription volumes.

The company reported adjusted earnings of $3.73 per share, beating estimates of $3.60 per share, according to IBES data from Refinitiv.

Total revenue rose 9.3 percent to $60.31 billion, ahead of estimates of $59.71 billion.

(Reporting by Tamara Mathias and Manojna Maddipatla in Bengaluru; Additional reporting by Sruthi Shankar; Editing by Shounak Dasgupta and Anil D'Silva)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Oil rises 2% as OPEC complies with production cuts
Business

Oil rises 2% as OPEC complies with production cuts

By Jessica Resnick-Ault NEW YORK (Reuters) - Oil prices strengthened on Wednesday, as OPEC and its allies were seen complying with a pact to cut oil supply in September, even as concerns loomed that recovery in fuel demand will be stalled by soaring global coronavirus cases. Early in the day crude was boosted by a bullish stock market. Even as equities whipsawed on pandemic worries, oil stayed higher, buoyed by expectations that OPEC could staunch a supply glut

Tesla's back-to-back price cuts bring sticker on U.S. Model S below $70,000
Business

Tesla's back-to-back price cuts bring sticker on U.S. Model S below $70,000

By Tina Bellon and C Nivedita (Reuters) - Tesla Inc will further cut the price of its Model S "Long Range" sedan in the United States to $69,420, the electric carmaker's chief executive, Elon Musk, announced in a tweet https://bit.ly/2H0JCP0 on Wednesday. The anticipated drop marks the second time this week Tesla has cut the price for the high-end sedan, following a 4% cut of the Model S's price in the United States on Tuesday to $71,990.

Trump cites teenaged son's bout with coronavirus in calling for schools to reopen
World

Trump cites teenaged son's bout with coronavirus in calling for schools to reopen

By Jeff Mason DES MOINES, Iowa (Reuters) - Under siege over his handling of the novel coronavirus pandemic, President Donald Trump on Wednesday cited what he said was his son's mild bout of the virus as a reason why American schools should reopen as soon as possible. Trump made the comment about his son, Barron, as the president swept into Iowa on a mission to shore up support in battleground states that he won in 2016 but is in danger of losing to Democrat Joe Biden barely three weeks before the election. First lady Melania Trump announced in a statement earlier in the day that the virus that struck both her and her husband had also infected their 14-year-old son